GlassScriptPhysician profile
Richard A Foreman
NPI 1033586680
$1,167.12
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $890 · 2024: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,067.17 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $281.37 | 2023-2024 | Opdivo |
| G1 Therapeutics, INC. | $152.86 | 2023 | Cosela |
| Incyte Corporation | $139.46 | 2023-2024 | Jakafi |
| Bayer Healthcare Pharmaceuticals INC. | $82.35 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $70.64 | 2023 | Libtayo |
| Lilly USA, LLC | $65.42 | 2023 | Verzenio, Jaypirca, Retevmo |
| Janssen Biotech, INC. | $50.33 | 2023 | Erleada, Balversa |
| Novartis Pharmaceuticals Corporation | $46.82 | 2023-2024 | |
| Sun Pharmaceutical Industries INC. | $39.38 | 2023 | Odomzo, Yonsa |
| Morphosys, US INC. | $39.01 | 2023 | Monjuvi |
| Blueprint Medicines Corporation | $37.75 | 2023 | Ayvakit |
| Glaxosmithkline, LLC. | $31.70 | 2023 | Shingrix |
| Rigel Pharmaceuticals, INC. | $30.55 | 2023 | Tavalisse, Rezlidhia |
| Merck Sharp & Dohme LLC | $20.87 | 2023 | Keytruda |
| Adc Therapeutics America, INC. | $20.45 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stemline Therapeutics INC. | $15.88 | 2023 | Orserdu |
| Amgen INC. | $14.95 | 2023 | Lumakras |
| Kite Pharma, INC. | $14.00 | 2023 | |
| Pharmacosmos Therapeutics INC. | $13.33 | 2023 | Monoferric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Foreman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.